My Child Has Inflammatory Bowel Disease : Why? What now? What s next?

Size: px
Start display at page:

Download "My Child Has Inflammatory Bowel Disease : Why? What now? What s next?"

Transcription

1 My Child Has Inflammatory Bowel Disease : Why? What now? What s next? George M. Zacur, M.D., M.S. Clinical Assistant Professor Department of Pediatrics and Communicable Diseases Division of Gastroenterology University of Michigan C.S. Mott Children s Hospital

2 Disclosures No disclosure Thank you Crohn's & Colitis Foundation

3 Objectives What is Inflammatory Bowel Disease (IBD)? Crohn Disease or Ulcerative Colitis? WHY? I don t have IBD. How did my child get it? The perfect storm of IBD Genetics and the environment WHAT NOW? How do we treat it? (Currently) Are these medications safe? What about surgery? Diet, probiotics, and fecal transplant. WHAT S NEXT? What should we expect? Disease course Future directions Transition of care

4 What is IBD? IBD is comprised of two distinct entities: Ulcerative Colitis (UC) and Crohn Disease (CD). About 15% with IBD have only colonic involvement, but cannot be distinguished between CD and UC, and this is termed Indeterminate Colitis (IC). IBD Ulcerative colitis Crohn Disease Indeterminate Colitis

5 What is IBD? Ulcerative Colitis (UC): Relapsing episodes of superficial mucosal inflammation, almost always affecting the rectum, in a continuous fashion Crohn Disease (CD): Characterized by transmural inflammation rather than superficial, skip lesions, fibrosis/strictures, fistulas, microperforations, and abscesses

6 What is IBD? Crohn Disease: Any part of the GI tract Can skip areas Rectal sparing Non-caseating granulomas Transmural inflammation Fistulas and abscesses Strictures (scar) common Ileum commonly involved Perianal disease 20% colon-only involved Ulcerative Colitis: Colon only Continuous No rectal sparing No granulomas Mucosal inflammation Can have inflammation in the stomach and duodenum Can have relative rectal sparing, cecal patch, or back-wash ileitis

7 What is IBD? Signs/Symptoms Crohn Disease Ulcerative Colitis Rectal Bleeding Abdominal Pain Diarrhea Weight loss Growth Failure Perianal Disease ++ Mouth Ulcers ++ + Erythema Nodosum + + Fevers ++ + Anemia Arthritis + + Adapted from CHDNF/NASPGHAN 2007

8 Geographic Distribution Cosnes, IBD 2011

9 IBD in the USA >1 million Americans have IBD (>1.5 million?) Incidence in the pediatric age group has doubled over the past decade Current estimates report more than 50,000 children have IBD (some report more than 80,000) % of adults with IBD developed symptoms or were diagnosed as children Rare before age 5 yrs, but reported as young as infancy Very Early Onset (VEO)-IBD

10 Percent of Cases Age of Onset 25 Years Loftus, Gastro 2003; 124:abstract 278

11 Gastro 2006 Age of Onset

12 WHY? I don t have IBD How did my child get it? The perfect storm of IBD Genetics and the environment

13 How did my child get IBD? The perfect storm of IBD Genetics ( 200 IBD genes) Immune System (Mucosal) IBD Gut Environment (Microbiome)

14 How did my child get IBD? The new perfect storm of IBD Genetics Immune System IBD Gut Flora Environmental Triggers

15 Genetics The most important risk factor for IBD is a positive family history (15-30%) Genetic influence is greater in CD than UC Genetically complex Genetic defects Mucosal barrier function Mucosal immune system 200 genes isolated more than half are common to both diseases Schreiber, Semin Immunology 2009 Williams, Inflamm Bowel Dis 2002 Orholm, Scand J Gastroenterol 2000

16 Gut Microbiome (Gut Bacteria) Frank, PNAS 2007

17 How did my child get IBD? Different theories: Hygiene theory? Early antibiotics? Vaginal birth vs C-Section? Breast feeding vs formula feeding? Environmental triggers?

18 Environmental Triggers Smoking: CD Oral contraceptives: CD & UC NSAIDs: CD & UC Vitamin D deficiency: CD Perinatal & childhood infections/microbial exposures? Stress? Food or food additives?

19 Theories of Triggers Genetics Triggers affecting the microbiome: Delivery method, Early diet Triggers that start inflammation: Infections, Antibiotics, NSAID s, Smoking Diet and lack of nutrients can influence inflammation IBD

20 WHAT NOW? How do we treat it? (Currently) Are these medications safe? What about surgery? Diet, probiotics, and fecal transplant.

21 How do we treat it? Principles of Medical Management Enhance quality of life while avoiding long-term toxicity Induction of Remission start the healing process Pitfall is premature withdrawal of inductive therapy: failure to complete induction virtually guarantees failure of maintenance Maintenance of Remission keep healing going Clinically resolution of symptoms (bleeding, urgency, passage of mucous and diarrhea) Endoscopically gut lining without ulcers/exudate/friability/ granularity Clinical remission precedes endoscopic remission which in turn precedes histologic remission and vice versa for flare

22 Therapy (old way) Disease Severity Resection/Diversion Colectomy Severe Moderate Surgery Biologics Methotrexate Azathioprine/6-MP Prednisone Anti-TNF s: Infliximab, Adalimumab, Certolizumab Ustekinumab Vedolizumab Mild CD Enteral Nutrition Budesonide Antibiotics Aminosalicylates UC

23 Therapy Disease Severity Severe Moderate Surgery Methotrexate Azathioprine/6-MP Prednisone Biologics Anti-TNF s: Infliximab, Adalimumab, Certolizumab Ustekinumab Vedolizumab Mild CD Enteral Nutrition Budesonide Antibiotics Aminosalicylates UC

24 Are Aminosalycilates safe? Aminosalycilates: Mesalamine, Sulfasalazine, Balsalazide Effective induction and maintenance of mild to moderate UC; effective maintenance for moderate UC after induction with steroids; do not work for Crohn Disease Tolerated well Headaches; Worse diarrhea/rectal bleeding Kidney disease (very rare) Oral and rectal combination better than oral alone, especially for distal UC (end of the colon)

25 Are Immunomodulators safe? Azathioprine (Imuran)/Mercaptopurine (6-MP) Effective for maintenance of CD and UC (earlier is better); need a bridging medication Pancreatitis, Rash, Flu-like symptoms, GI intolerance Lower white blood cell count Liver damage (temporary) rare Skin Cancer rare Lymphoma extremely rare (4 per 10,000) Methotrexate Used as monotherapy or combination with anti-tnf s better for CD Nausea Liver and lung damage (temporary and rare) Birth defects Risk of cancer is small to negligible (need more data)

26 Are Biologics safe? Anti-TNF s: Infliximab (Remicade), Adalimumab (Humira), Certolizumab (Cimzia), Golimumab (Simponi) Effective for induction and maintenance of remission in CD and UC Highly effective for fistula therapy in CD (best!) Rash, fever, headache Low risk of serious infections, except for TB, Varicella, and Influenza Antibodies and/or loss of response Little evidence for increase risk of cancer with Anti-TNF alone

27 Are Biologics safe? Ustekinumab (Stelara) Initially used for psoriasis found to be effective for CD Slightly better side effect profile than the anti-tnf s Effective for CD only One infusion, then every 8 week injection Still need more data fistulae, strictures, recurrence post-op Vedolizumab (Entyvio) Both take months to work. Significantly better side effect profile Effective for both UC and CD (UC>CD) Infusion schedule similar to other biologics Still need more data fistula, stricture

28 Are Steroids safe? Corticosteroids: Prednisone, Prednisolone, Methylprednisolone, Hydrocortisone Extremely effective anti-inflammatory Not to be used alone, but rather as a bridge NOT MAINTENANCE DRUGS! Short and long-term side effects: Skin problems, stretch marks Infections! Growth failure! Bone disease osteoporosis, degenerative joint disease Hypertension, Diabetes, Cataracts, Glaucoma Gastritis, ulcers

29 What about surgery? Surgery is not necessarily a failure of medication >70% of CD patients will undergo one surgery;? 1/3 UC Colectomy (colon removal) UC more than CD Severe UC, refractory to steroids/medications, severe Crohn colitis Pouchitis, cuffitis, diarrhea Diversion (Temporizing Ileostomy) CD more than UC Severe perianal CD, severe Crohn colitis, severe UC Diarrhea, dehydration Small bowel resection Ileocecal resection Most common surgery of CD Resume/reinitiate therapy Recurrence (Crohn Disease returns where ends are connected)

30 Do we have to use medications? Risks of poor outcomes from the diseases themselves are higher than the side effects of medical or surgical therapy Crohn Disease: Growth failure, short stature, poor nutrition Fistula, abscess, infection Stricture, small bowel obstruction Colon cancer Death Ulcerative Colitis: Profuse diarrhea, severe rectal bleeding, anemia, transfusions Growth failure, infection Toxic megacolon, perforation Colon cancer Death

31 Diet Theory: A regular diet contains harmful components and can alter the gut microbiome which can lead to inflammation. High dietary intakes of total fats, polyunsaturated fatty acids, omega-6 and meat were associated with an increased risk of CD and UC High fiber and fruit intakes were associated with decreased CD risk (but not UC) High vegetable intake was associated with decreased UC risk. Hou, Am J Gastroenterol 2011 Ananthakrishnan, Gastro 2013

32 Enteral Nutrition Elemental (formula) diet: % for 6-8 weeks for induction of remission of CD Study that compares partial vs exclusive enteral nutrition: GREAT! Greater mucosal healing with a more formula diet Decreased fecal calprotectin THEN WHAT? PLEASE study, AIBD, Orlando 2014 Study looking at partial enteral nutrition with a CD exclusion diet: Improvement in labs and disease severity scoring High remission rate Sigall-Boneh, IBD 2014

33 Specialized Diets Gluten-free Low FODMAPS No/Low dairy Low roughage Paleo Diet There is no evidence that these diets improve inflammation or prevent disease complications, although they may improve symptoms for some patients.

34 Probiotics Probiotics: "live microorganisms, which when consumed in adequate amounts, confer a health effect on the host No good evidence that they improve CD or UC Some good evidence they are effective in prevention of pouchitis after colectomy with pouch formation May help symptoms, but not the disease (can t hurt unless there is hardware) Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria, October 2001

35 Fecal Transplant Fecal Microbiota Transplant (FMT): stool is collected from a tested donor, mixed with saline or other solution, strained, and placed in a patient, by endoscopy, enteral tube (NG or NJ), or enema. May work in some specific cases (C. diff) No good evidence for use in IBD need more studies Harmful if not done correctly (Do not try this at home!)

36 WHAT S NEXT? What should we expect? Disease course Future directions Transition of care

37 What should we expect? 1 st year may be rough Many medications initially Labs Good and bad days Flares Scopes Imaging, MRI Surgery GOAL: NORMAL LIFE!

38 Future Directions Goal of therapy: Optimizing efficacy while minimizing toxicity fancy way of saying finding the right medication, with minimal side effects, and best at treating the disease Individualized therapy based on multiple factors such as disease location, genetics, molecular makeup Altering the diet to modify the gut microbiome as a potential for disease prevention and/or therapy Maybe immunization against bacteria causing IBD?

39 Research

40 Transition of care Know: Your disease Your medications what, why, how much, side effects, interactions Your test results and what they mean Develop Independence and Assertiveness: Take responsibility for knowing medications and adherence Make your own appointments with your doctor tell your history, don t rely on your parents Plan for the future how will you manage your disease at school? Work? Health Insurance? Transition not Transfer: Make introductions dialogue between docs, not just records

41 Transition: goals and milestones

42 Prior to transitioning Patients: Speak up! Take ownership of your health and your treatment. Parents: Allow child to lead the appointment.

43 When transitioning Do your research Have pediatric doctor speak with new doctor Prepare yourself before appointments GET TO KNOW Familiarize yourself with insurance information Read all medical documents YOUR SOCIAL WORKER!

44 THANK YOU!

Efficacy and Safety of Treatment for Pediatric IBD

Efficacy and Safety of Treatment for Pediatric IBD Efficacy and Safety of Treatment for Pediatric IBD Andrew B. Grossman MD Co-Director, Center for Pediatric Inflammatory Bowel Disease Assistant Professor of Clinical Pediatrics Division of Gastroenterology,

More information

Efficacy and Safety of Treatment for Pediatric IBD

Efficacy and Safety of Treatment for Pediatric IBD Efficacy and Safety of Treatment for Pediatric IBD Andrew B. Grossman MD Co-Director, Center for Pediatric Inflammatory Bowel Disease Associate Professor of Clinical Pediatrics Division of Gastroenterology,

More information

Garrick Brown, MD. Digestive Health Specialists Tacoma Gig Harbor

Garrick Brown, MD. Digestive Health Specialists Tacoma Gig Harbor Garrick Brown, MD Digestive Health Specialists Tacoma Gig Harbor Today s Objectives Define IBD, its potential causes and diagnosis Discuss management and treatment Discuss complementary and alternative

More information

PEDIATRIC INFLAMMATORY BOWEL DISEASE

PEDIATRIC INFLAMMATORY BOWEL DISEASE PEDIATRIC INFLAMMATORY BOWEL DISEASE Alexis Rodriguez, MD Pediatric Gastroenterology Advocate Children s Hospital Disclosers Abbott Nutrition - Speaker Inflammatory Bowel Disease Chronic inflammatory disease

More information

Medical Therapy for Pediatric IBD: Efficacy and Safety

Medical Therapy for Pediatric IBD: Efficacy and Safety Medical Therapy for Pediatric IBD: Efficacy and Safety Betsy Maxwell, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Pediatric IBD: Defining Remission

More information

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG Treatment of Inflammatory Bowel Disease Michael Weiss MD, FACG What is IBD? IBD is an immune-mediated chronic intestinal disorder, characterized by chronic or relapsing inflammation within the GI tract.

More information

Understanding Inflammatory Bowel Diseases (IBD):

Understanding Inflammatory Bowel Diseases (IBD): Understanding Inflammatory Bowel Diseases (IBD): What Every Patient Needs to Know William H Holderman, MD Digestive Health Specialists Tacoma, WA Today s Objectives Define IBD, its potential causes and

More information

Outline. Biologic Drugs in Inflammatory Bowel Disease Dr. Jason Etzel MD The Vancouver Clinic. Biologic Drugs. Biologic Drugs. Biologic Drugs Anti-TNF

Outline. Biologic Drugs in Inflammatory Bowel Disease Dr. Jason Etzel MD The Vancouver Clinic. Biologic Drugs. Biologic Drugs. Biologic Drugs Anti-TNF Outline Biologic Drugs in Inflammatory Bowel Disease Dr. Jason Etzel MD The Vancouver Clinic Types of biologic drugs How do they work? How effective are they? Safety/Toxicity concerns with biologics Biologic

More information

I B D. etter than this. isease UNDERSTANDING INFLAMMATORY BOWEL DISEASES

I B D. etter than this. isease UNDERSTANDING INFLAMMATORY BOWEL DISEASES I B D m etter than this isease UNDERSTANDING INFLAMMATORY BOWEL DISEASES What types of people have learned how to manage their IBD? Athletes Musicians Firefighters DOCTORS HEROES Artists Presidents Actors

More information

ULCERATIVE COLITIS. Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC

ULCERATIVE COLITIS. Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC ULCERATIVE COLITIS Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC What is Ulcerative Colitis? Ulcerative colitis (UC) is a disease marked by inflammation

More information

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition IBD 101 Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Objectives Identify factors involved in the development of inflammatory bowel

More information

Top 10 Things you need to know about IBD. Suresh Pola, MD Kaiser San Diego

Top 10 Things you need to know about IBD. Suresh Pola, MD Kaiser San Diego Top 10 Things you need to know about IBD Suresh Pola, MD Kaiser San Diego Top 10 Things to Know: IBD What you can eat How to treat the pain Not all diarrhea is a flare Ways to reduce your risk of getting

More information

Crohn s Disease. Resident Lecture 1/17/19

Crohn s Disease. Resident Lecture 1/17/19 Crohn s Disease Resident Lecture 1/17/19 Objectives Features/Classification of Crohn s Disease Medical Treatment Surgical Indications Surgical Considerations 2 Case 25 yo F presents to your office with

More information

Slide 1 Medications in inflammatory bowel disease a primer for health care providers. Slide 2. Slide 3 Theory of pathogenesis. IBD - epidemiology

Slide 1 Medications in inflammatory bowel disease a primer for health care providers. Slide 2. Slide 3 Theory of pathogenesis. IBD - epidemiology Slide 1 Medications in inflammatory bowel disease a primer for health care providers Athos Bousvaros, MD Associate director Inflammatory Bowel Disease Center Boston Children s Hospital 617 355 2962 Slide

More information

Crohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine

Crohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine Crohn's disease Crohn's disease is an inflammatory condition of the digestive tract that affects children and adults. Common features of Crohn's disease include mouth sores, diarrhea, abdominal pain, weight

More information

Update in Pediatric IBD: 2018

Update in Pediatric IBD: 2018 Update in Pediatric IBD: 2018 Jeffrey S. Hyams, MD Head, Division of Digestive Diseases, Hepatology and Nutrition Mandell-Braunstein Family Endowed Chair in Pediatric Inflammatory Bowel Disease Connecticut

More information

NEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL

NEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL NEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL CROHN S DISEASE Chronic disease of uncertain etiology Etiology- genetic, environmental, and infectious Transmural

More information

Treatment Options. Suresh Pola, MD Kaiser San Diego

Treatment Options. Suresh Pola, MD Kaiser San Diego Treatment Options Suresh Pola, MD Kaiser San Diego Overview of Treatments! Medications! Diet! Complementary and Alternative Medicines! How to treat Pain Treatment Goals and Target! Goals of Treatment should

More information

INFLAMMATORY BOWEL DISEASE 101: From Hurdling New Diagnosis to Optimizing Treatments

INFLAMMATORY BOWEL DISEASE 101: From Hurdling New Diagnosis to Optimizing Treatments INFLAMMATORY BOWEL DISEASE 101: From Hurdling New Diagnosis to Optimizing Treatments Phillip Minar, MD Pediatric Gastroenterologist Cincinnati Children s Hospital Medical Center Objectives of Session What

More information

Dietary Options for Inflammatory Bowel Disease

Dietary Options for Inflammatory Bowel Disease Dietary Options for Inflammatory Bowel Disease Michael J. Rosen, MD, MSCI Schubert-Martin Inflammatory Bowel Disease Center Learning objectives Worldwide rise in the incidence of IBD The relationship between

More information

Treating Crohn s and Colitis in the ASC

Treating Crohn s and Colitis in the ASC Treating Crohn s and Colitis in the ASC Kimberly M Persley, MD Texas Digestive Disease consultants TASC Meeting Outline IBD 101 Diagnosis Treatment Burden of Disease Role of ASC Inflammatory Bowel Disease

More information

How do I choose amongst medicines for inflammatory bowel disease. Maria T. Abreu, MD

How do I choose amongst medicines for inflammatory bowel disease. Maria T. Abreu, MD How do I choose amongst medicines for inflammatory bowel disease Maria T. Abreu, MD Overview of IBD Pathogenesis Bacterial Products Moderately Acutely Inflamed Chronic Inflammation = IBD Normal Gut Mildly

More information

INFLAMMATORY BOWEL DISEASE 101: From Hurdling New Diagnosis to Optimizing Treatments

INFLAMMATORY BOWEL DISEASE 101: From Hurdling New Diagnosis to Optimizing Treatments INFLAMMATORY BOWEL DISEASE 101: From Hurdling New Diagnosis to Optimizing Treatments Phillip Minar, MD, MS Pediatric Gastroenterologist Cincinnati Children s Hospital Medical Center 3.3.2019 Objectives

More information

Ali Keshavarzian MD Rush University Medical Center

Ali Keshavarzian MD Rush University Medical Center Treatment: Step Up or Top Down? Ali Keshavarzian MD Rush University Medical Center Questions What medication should IBD be treated with? Can we predict which patients with IBD are high risk? Is starting

More information

Beyond Anti TNFs: positioning of other biologics for Crohn s disease. Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center

Beyond Anti TNFs: positioning of other biologics for Crohn s disease. Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center Beyond Anti TNFs: positioning of other biologics for Crohn s disease Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center Objectives: To define high and low risk patient and disease features

More information

Welcome to Week 2 of the Crohn s & Colitis Foundation of America (CCFA) Online Support Group.

Welcome to Week 2 of the Crohn s & Colitis Foundation of America (CCFA) Online Support Group. Welcome to Week 2 of the Crohn s & Colitis Foundation of America (CCFA) Online. Last week s material consisted of an overview of inflammatory bowel diseases (IBD), specifically Crohn s disease and ulcerative

More information

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition

IBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition IBD 101 Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Objectives Identify factors involved in the development of inflammatory bowel

More information

The Road to Remission

The Road to Remission The Road to Remission Understanding, Treating and Living with Inflammatory Bowel Disease IBDCenterOrlando.com As many as 1.5 million Americans currently suffer from inflammatory bowel disease (IBD), and

More information

Medical therapies and IBD

Medical therapies and IBD Medical therapies and IBD Although there is no cure for IBD, there are many treatment options available. There is no standard treatment for IBD that is effective in all situations or for all patients,

More information

Speaker Introduction

Speaker Introduction Speaker Introduction Stephen B. Hanauer, MD Professor of Medicine and Clinical Pharmacology University of Chicago Pritzker School of Medicine Chief of Gastroenterology, Hepatology, and Nutrition University

More information

Definitions. Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency)

Definitions. Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency) CROHN S DISEASE Definitions Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency) Recurrence: The reappearance of lesions after surgical resection Endoscopic remission:

More information

Dr. Elmer Schabel, MD. Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany (No conflicts of interest)

Dr. Elmer Schabel, MD. Bundesinstitut für Arzneimittel und Medizinprodukte, Bonn, Germany (No conflicts of interest) EMA workshop on the development of new medicinal products for the treatment of ulcerative colitis and Crohn s disease Overview of authorised medicines for IBD in Europe - previous regulatory positions

More information

IBD Understanding Your Medications. Thomas V. Aguirre, MD Santa Barbara GI Consultants

IBD Understanding Your Medications. Thomas V. Aguirre, MD Santa Barbara GI Consultants IBD Understanding Your Medications Thomas V. Aguirre, MD Santa Barbara GI Consultants IBD Understanding Your Medications (& Your Doctor) Thomas V. Aguirre, MD Santa Barbara GI Consultants Disclosure I

More information

10/23/2014. Program Goals

10/23/2014. Program Goals Program Goals Help you understand ulcerative colitis and its effects Review current treatments, including medications, and surgery Provide tips for managing your disease through diet and complementary

More information

CCFA. Crohns Disease vs UC: What is the best treatment for me? November

CCFA. Crohns Disease vs UC: What is the best treatment for me? November CCFA Crohns Disease vs UC: What is the best treatment for me? November 8 2009 Ellen J. Scherl,, MD, FACP,AGAF Roberts Inflammatory Bowel Disease Center Weill Medical College Cornell University New York

More information

An Update on the Biologic Treatment for Patients with Inflammatory Bowel Disease. David A. Schwartz, MD

An Update on the Biologic Treatment for Patients with Inflammatory Bowel Disease. David A. Schwartz, MD An Update on the Biologic Treatment for Patients with Inflammatory Bowel Disease David A. Schwartz, MD Director, Inflammatory Bowel Disease Center Associate Professor of Medicine Vanderbilt University

More information

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic INFLAMMATORY BOWEL DISEASE Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic WHAT IS INFLAMMATORY BOWEL DISEASE (IBD)? Chronic inflammation of the intestinal tract Two related

More information

Patho Basic Chronic Inflammatory Bowel Diseases. Jürg Vosbeck Pathology

Patho Basic Chronic Inflammatory Bowel Diseases. Jürg Vosbeck Pathology Patho Basic Chronic Inflammatory Bowel Diseases Jürg Vosbeck Pathology General Group of chronic relapsing diseases with chronic bloody or watery diarrhea Usually ulcerative colitis (UC) or Crohn s disease

More information

Disclosures. What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists

Disclosures. What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists Disclosures No financial relationships to disclose. 1 Learning Objectives Case 24M with ileocolonic

More information

Selby Inflamm Bowel Dis. 2008:14:

Selby Inflamm Bowel Dis. 2008:14: Medical Management of Inflammatory Bowel Disease Freddy Caldera D.O. Assistant Professor Division of Gastroenterology Objectives Discuss Crohn s disease and Ulcerative Colitis Discuss Medications for Inflammatory

More information

Surgical Management of IBD. Val Jefford Grand Rounds October 14, 2003

Surgical Management of IBD. Val Jefford Grand Rounds October 14, 2003 Surgical Management of IBD Val Jefford Grand Rounds October 14, 2003 Introduction Important Features Clinical Presentation Evaluation Medical Treatment Surgical Treatment Cases Overview Introduction Two

More information

What is Crohn's disease?

What is Crohn's disease? What is Crohn's disease? Crohn's disease is a chronic inflammatory disorder that causes inflammation of the digestive tract. It can affect any area of the GI tract, from the mouth to the anus, but it most

More information

What is ulcerative colitis?

What is ulcerative colitis? What is ulcerative colitis? Ulcerative colitis is a disease that causes inflammation and sores, called ulcers, in the lining of the rectum and colon. Ulcers form where inflammation has killed the cells

More information

WHAT IS ULCERATIVE COLITIS?

WHAT IS ULCERATIVE COLITIS? 235 60th Street, West New York, NJ 07093 T: (201) 854-4646 F: (201) 854-4647 810 Main Street, Hackensack, NJ 07601 T: (201) 488-0095 Ulcerative Colitis WHAT IS ULCERATIVE COLITIS? Ulcerative colitis is

More information

What Will This Talk Cover? 101: The Basics of Inflammatory Bowel Disease. Terms & Abbreviations. What Is Normal GI Anatomy?

What Will This Talk Cover? 101: The Basics of Inflammatory Bowel Disease. Terms & Abbreviations. What Is Normal GI Anatomy? 101: The Basics of Inflammatory Bowel Disease What Will This Talk Cover? What is IBD? What causes it? What are complications of it? How do I find out if I have IBD? How do we treat IBD? Jennifer Choi,

More information

Crohn's Disease. What causes Crohn s disease? What are the symptoms?

Crohn's Disease. What causes Crohn s disease? What are the symptoms? Crohn's Disease Crohn s disease is an ongoing disorder that causes inflammation of the digestive tract, also referred to as the gastrointestinal (GI) tract. Crohn s disease can affect any area of the GI

More information

This program is supported by an educational grant from Janssen Biotech Inc., Shire, Inc., and a sponsorship from Takeda

This program is supported by an educational grant from Janssen Biotech Inc., Shire, Inc., and a sponsorship from Takeda This program is supported by an educational grant from Janssen Biotech Inc., Shire, Inc., and a sponsorship from Takeda Today s Presenter Adam S. Cheifetz, MD Director, Center for Inflammatory Bowel Disease

More information

COPYRIGHT. Inflammatory Bowel Disease What Every Clinician Needs to Know. Adam S. Cheifetz, MD. Director, Center for Inflammatory Bowel Disease

COPYRIGHT. Inflammatory Bowel Disease What Every Clinician Needs to Know. Adam S. Cheifetz, MD. Director, Center for Inflammatory Bowel Disease Inflammatory Bowel Disease What Every Clinician Needs to Know Adam S. Cheifetz, MD Director, Center for Inflammatory Bowel Disease Beth Israel Deaconess Medical Center Associate Professor of Medicine Harvard

More information

Inflammatory Bowel Diseases

Inflammatory Bowel Diseases Objectives Today s discussion will address the following topics: Similarities and differences between Crohn s disease (CD) and ulcerative colitis (UC) Risks and benefits of medication, surgery, and integrative

More information

Michael D. Kreines, M.D.

Michael D. Kreines, M.D. Michael D. Kreines, M.D. Gastroenterology Section Chief Medical Director, IBD Program The Christ Hospital of Cincinnati Ohio GI and Liver Institute www.ohiogi.com This Year s Story How to figure out how

More information

INFLAMMATORY BOWEL DISEASE 101: Understanding Your Child s Diagnosis

INFLAMMATORY BOWEL DISEASE 101: Understanding Your Child s Diagnosis INFLAMMATORY BOWEL DISEASE 101: Understanding Your Child s Diagnosis Phillip Minar, MD Pediatric Gastroenterologist Cincinnati Children s Hospital Medical Center Objectives What is IBD Crohn s disease

More information

Best Practices in the Diagnosis and Treatment of Inflammatory Bowel Disease

Best Practices in the Diagnosis and Treatment of Inflammatory Bowel Disease Best Practices in the Diagnosis and Treatment of Inflammatory Bowel Disease Mark Lazarev, MD Summary Inflammatory bowel disease (IBD) is a complex disease that is costly both in terms of medical costs

More information

Inflammatory Bowel Disease Medical Exam Questionnaire

Inflammatory Bowel Disease Medical Exam Questionnaire Patient Name: MR: Date: Name DOB / / Age Marital Status Race Gender M / F Height Present Weight Usual Weight Insurance Managed Care Self referral Yes No Yes No Yes No Primary Care Physician Referring Physician

More information

New treatment options in UC. Rob Bryant IBD Consultant Royal Adelaide Hospital

New treatment options in UC. Rob Bryant IBD Consultant Royal Adelaide Hospital New treatment options in UC Rob Bryant IBD Consultant Royal Adelaide Hospital Talk Outline 1. Raising expectations 2. Optimising UC therapy 3. Clinical trials 4. What s new on the PBS? 5. Questions 1.

More information

Regulatory Status FDA-approved indications: Entyvio is an α4β7integrin receptor antagonist indicated for: (1)

Regulatory Status FDA-approved indications: Entyvio is an α4β7integrin receptor antagonist indicated for: (1) Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.50.12 Subject: Entyvio Page: 1 of 7 Last Review Date: September 20, 2018 Entyvio Description Entyvio

More information

Improving outcome of Inflammatory Bowel Disease in children

Improving outcome of Inflammatory Bowel Disease in children Improving outcome of Inflammatory Bowel Disease in children Dinesh Pashankar, MD Pediatric Gastroenterologist Director- Pediatric IBD program Yale University School of Medicine Pediatric Gastroenterology

More information

What is Inflammatory Bowel Disease (IBD)?

What is Inflammatory Bowel Disease (IBD)? INFLAMMATORY BOWEL DISEASE (IBD) What is Inflammatory Bowel Disease (IBD)? Inflammatory bowel disease, or IBD, is when there is inflammation, or swelling, in the gastrointestinal (GI) tract and a lifelong

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 3 October 2012

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 3 October 2012 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 3 October 2012 REMICADE 100 mg, powder for concentrate for solution for infusion B/1 vial (CIP code: 562 070-1) Applicant:

More information

Is there an anti-inflammatory diet in IBD?

Is there an anti-inflammatory diet in IBD? CCFA North Texas Chapter IBD education symposium December 2, 2017, Dallas, TX Is there an anti-inflammatory diet in IBD? Themos Dassopoulos, MD Director, Baylor Scott and White Center for IBD Baylor University

More information

The ABCs of Inflammatory Bowel Disease. Jennifer Choi, M.D. Associate Director March 31, 2012

The ABCs of Inflammatory Bowel Disease. Jennifer Choi, M.D. Associate Director March 31, 2012 The ABCs of Inflammatory Bowel Disease Jennifer Choi, M.D. Associate Director March 31, 2012 What Will This Talk Cover? What is IBD? What causes it? What are complications of it? How do I find out if I

More information

This program is supported by an educational grant from Janssen Biotech Inc, and a sponsorship from Takeda.

This program is supported by an educational grant from Janssen Biotech Inc, and a sponsorship from Takeda. This program is supported by an educational grant from Janssen Biotech Inc, and a sponsorship from Takeda. Objectives Today s discussion will address the following topics: Similarities and differences

More information

Pharmacotherapy of Inflammatory Bowel Disorder

Pharmacotherapy of Inflammatory Bowel Disorder PHARMACY / MEDICAL POLICY 5.01.563 Pharmacotherapy of Inflammatory Bowel Disorder Effective Date: Feb. 14, 2018 Last Revised: April 1, 2018 Replaces: Extracted from 5.01.550 RELATED MEDICAL POLICIES: 11.01.523

More information

Inflammatory Bowel Disease

Inflammatory Bowel Disease Inflammatory Bowel Disease Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn's disease andulcerative colitis are the principal types of inflammatory

More information

Ileal Pouch Anal Anastomosis: The Preferred Method of Reconstruction after Proctocolectomy in Children

Ileal Pouch Anal Anastomosis: The Preferred Method of Reconstruction after Proctocolectomy in Children Ileal Pouch Anal Anastomosis: The Preferred Method of Reconstruction after Proctocolectomy in Children Stephanie Jones, D.O. Surgical Fellow March 21, 2011 Ulcerative Colitis Spectrum of inflammatory bowel

More information

There is no single IBD diet

There is no single IBD diet Nutrition and IBD There is no single IBD diet Nutrition plays an important role in health, during times of IBD disease activity as well as during remission. Although diet does not cause or cure IBD, the

More information

Treatment Goals. Current Therapeutic Pyramids Crohn s Disease Ulcerative Colitis 11/14/10

Treatment Goals. Current Therapeutic Pyramids Crohn s Disease Ulcerative Colitis 11/14/10 Current Management of IBD: From Conventional Agents to Biologics Stephen B. Hanauer, M.D. University of Chicago Treatment Goals Induce and maintain response/ remission Prevent complications Improve quality

More information

How to manage your IBD patient: Tips for diagnosis and care

How to manage your IBD patient: Tips for diagnosis and care How to manage your patient: Tips for diagnosis and care Oriana M. Damas, M.D. Assistant Prof Clinical Medicine Division of Gastroenterology No relevant disclosures Case Presentation: A.R. 32 yo woman with

More information

Pouchitis and Cuffitis A bloody mess. Sze-Lin Peng Colorectal Surgeon Counties Manukau District Health Board

Pouchitis and Cuffitis A bloody mess. Sze-Lin Peng Colorectal Surgeon Counties Manukau District Health Board Pouchitis and Cuffitis A bloody mess Sze-Lin Peng Colorectal Surgeon Counties Manukau District Health Board Ileal-pouch anal anastomosis https://www.pennmedicine.org/for-health-care-professionals/for-physicians/physician-education-and-resources/clinicalbriefings/2018/february/total-proctocolectomy-with-jpouch-reconstruction-for-ulcerative-colitis

More information

INFLAMMATORY BOWEL DISEASE

INFLAMMATORY BOWEL DISEASE 1. Medical Condition INFLAMMATORY BOWEL DISEASE (IBD) specifically includes Crohn s disease (CD) and ulcerative colitis (UC) but also includes IBD unclassified (IBDu), seen in about 10% of cases. These

More information

The Role of Surgery in Inflammatory Bowel Disease. Cory D Barrat, MD Colon and Rectal Surgeon Mercy Health

The Role of Surgery in Inflammatory Bowel Disease. Cory D Barrat, MD Colon and Rectal Surgeon Mercy Health The Role of Surgery in Inflammatory Bowel Disease Cory D Barrat, MD Colon and Rectal Surgeon Mercy Health THANKS FOR INVITING ME! I have no financial disclosures Outline - Who am I and what do I do? -

More information

INFLAMMATORY BOWEL DISEASE (IBD): CROHN S DISEASE

INFLAMMATORY BOWEL DISEASE (IBD): CROHN S DISEASE INFLAMMATORY BOWEL DISEASE (IBD): CROHN S DISEASE Symptoms The symptoms of Crohn s disease can vary from person to person, based on where the disease is in the body and how bad the inflammation is. The

More information

ENTYVIO (VEDOLIZUMAB)

ENTYVIO (VEDOLIZUMAB) ENTYVIO (VEDOLIZUMAB) UnitedHealthcare Community Plan Medical Benefit Drug Policy Policy Number: CS2017D0053F Effective Date: July 1, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...

More information

Certain genes passed on from parent to child increase the risk of developing Crohn's disease, if the right trigger occurs.

Certain genes passed on from parent to child increase the risk of developing Crohn's disease, if the right trigger occurs. Topic Page: Crohn's disease Definition: Crohn's disease from Benders' Dictionary of Nutrition and Food Technology Chronic inflammatory disease of the bowel, commonly the terminal ileum, of unknown aetiology,

More information

Pharmacotherapy of Inflammatory Bowel Disorder

Pharmacotherapy of Inflammatory Bowel Disorder PHARMACY / MEDICAL POLICY 5.01.563 Pharmacotherapy of Inflammatory Bowel Disorder Effective Date: June 9, 2019* Last Revised: Feb. 12, 2019 Replaces: Extracted from 5.01.550 RELATED MEDICAL POLICIES: 11.01.523

More information

The role of Surgery and Stomas in IBD

The role of Surgery and Stomas in IBD The role of Surgery and Stomas in IBD When do I need it? Can I avoid it? How do I live with it? Kyle G. Cologne, MD Assistant Professor of Surgery USC Division of Colorectal Surgery Topics Surgical Differences

More information

IBD Module 2: Medication and Patient Management. Kami Roake, PharmD Rheumatology & Gastroenterology Pharmacist University of Utah Hospitals & Clinics

IBD Module 2: Medication and Patient Management. Kami Roake, PharmD Rheumatology & Gastroenterology Pharmacist University of Utah Hospitals & Clinics IBD Module 2: Medication and Patient Management Kami Roake, PharmD Rheumatology & Gastroenterology Pharmacist University of Utah Hospitals & Clinics Objectives Describe current treatment guidelines and

More information

Predicting the natural history of IBD. Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium

Predicting the natural history of IBD. Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium Predicting the natural history of IBD Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium Patient 1 Patient 2 Age 22 Frequent cramps and diarrhea for 6 months Weight

More information

Inflammatory Bowel Diseases (IBD) Clinical aspects Nitsan Maharshak M.D., IBD Center, Department of Gastroenterology and Liver Diseases Tel Aviv Soura

Inflammatory Bowel Diseases (IBD) Clinical aspects Nitsan Maharshak M.D., IBD Center, Department of Gastroenterology and Liver Diseases Tel Aviv Soura Inflammatory Bowel Diseases (IBD) Clinical aspects Nitsan Maharshak M.D., IBD Center, Department of Gastroenterology and Liver Diseases Tel Aviv Sourasky Medical Center Tel Aviv, Israel IBD- clinical features

More information

Ulcerative Colitis Therapy. Faculty Disclosure. Acknowledgements 28/11/2013. Amy Morse November 30/13

Ulcerative Colitis Therapy. Faculty Disclosure. Acknowledgements 28/11/2013. Amy Morse November 30/13 Ulcerative Colitis Therapy Amy Morse November 30/13 GI for GP s Jasper AB Faculty Disclosure Faculty: Amy Morse Relationships with commercial interests: Grants/Research Support: Therapeutic Fellowship

More information

P a g e 1. Inflammatory Bowel Disease Guidelines

P a g e 1. Inflammatory Bowel Disease Guidelines P a g e 1 Inflammatory Bowel Disease Guidelines Introduction Inflammatory bowel disease (IBD) is a chronic inflammatory disease affecting the gastrointestinal (GI) system. It is comprised of two major

More information

Personalized Medicine in IBD

Personalized Medicine in IBD Personalized Medicine in IBD Anita Afzali MD, MPH Assistant Professor of Medicine Director, Inflammatory Bowel Diseases Program University of Washington Harborview Medical Center CCFA April 2 nd, 2016

More information

Doncaster & Bassetlaw Medicines Formulary

Doncaster & Bassetlaw Medicines Formulary Doncaster & Bassetlaw Medicines Formulary Section 1.5 Chronic Bowel Disorders (including IBD) Aminosalicylates: Mesalazine 400mg and 800mg MR Tablets (Octasa) Mesalazine 1.2g MR Tablets (Mezavant XL) Mesalazine

More information

Surgery and Stomas in IBD When do I need it? Can I avoid it? How do I live with it?

Surgery and Stomas in IBD When do I need it? Can I avoid it? How do I live with it? Surgery and Stomas in IBD When do I need it? Can I avoid it? How do I live with it? Kyle G. Cologne, MD Assistant Professor of Surgery USC Division of Colorectal Surgery Topics Surgical Differences between

More information

IBD Updates. Themes in IBD IBD management journey. New tools for therapeutic monitoring. First-line treatment in IBD

IBD Updates. Themes in IBD IBD management journey. New tools for therapeutic monitoring. First-line treatment in IBD IBD Updates Maria T. Abreu, MD University of Miami Miller School of Medicine Miami, Florida Themes in IBD 213 First-line treatment in IBD New tools for therapeutic monitoring Biologic therapy for CD and

More information

Best Practices in the Diagnosis and Treatment of Inflammatory Bowel Disease

Best Practices in the Diagnosis and Treatment of Inflammatory Bowel Disease Mark Lazarev, MD November 14, 2013 Assistant Professor of Medicine, Johns Hopkins University School of Medicine Best Practices in the Diagnosis and Treatment of Inflammatory Bowel Disease 1 Talk outline

More information

Mucosal Healing in Crohn s Disease. Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium

Mucosal Healing in Crohn s Disease. Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium Mucosal Healing in Crohn s Disease Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium Mucosal Lesions in CD: General Features CD can affect the entire GI tract

More information

Carefirst.+.V Family of health care plans

Carefirst.+.V Family of health care plans Carefirst.+.V Family of health care plans CVS care mark POLICY Document for ENTYVIO The overall objective of this policy is to support the appropriate and cost effective use of the medication, specific

More information

Managing. Inflammatory Bowel Disease. Slide 1. Slide 2. Slide 3. Disclosures. Vijay Yajnik, MD., PhD 01/25/14. None relevant to this talk

Managing. Inflammatory Bowel Disease. Slide 1. Slide 2. Slide 3. Disclosures. Vijay Yajnik, MD., PhD 01/25/14. None relevant to this talk Slide 1 Managing Inflammatory Bowel Disease Vijay Yajnik, MD., PhD 01/25/14 Slide 2 Disclosures None relevant to this talk 2 Slide 3 Inflammatory Bowel Disease Topics Covered My friend called me and she

More information

Anne Griffiths MD, FRCPC. SickKids Hospital, University of Toronto. Buenos Aires, August 16, 2014

Anne Griffiths MD, FRCPC. SickKids Hospital, University of Toronto. Buenos Aires, August 16, 2014 Management and Medical Therapies for Crohn disease: strategies to enhance mucosal healing Anne Griffiths MD, FRCPC SickKids Hospital, University of Toronto Buenos Aires, August 16, 2014 New onset Crohn

More information

Biologic Therapy for Inflammatory. Is Top-Down Too Top-Heavy? S. Devi Rampertab, MD, FACG, AGAF Associate Professor of Medicine University of Florida

Biologic Therapy for Inflammatory. Is Top-Down Too Top-Heavy? S. Devi Rampertab, MD, FACG, AGAF Associate Professor of Medicine University of Florida Biologic Therapy for Inflammatory Bowel Disease: Is Top-Down Too Top-Heavy? S. Devi Rampertab, MD, FACG, AGAF Associate Professor of Medicine University of Florida Learning Objectives Evaluate evidence

More information

Surgical Therapies for the Treatment of IBD!

Surgical Therapies for the Treatment of IBD! Surgical Therapies for the Treatment of IBD! Andrew A Shelton, MD Clinical Professor of Surgery Stanford Hospital and Clinics Section of Colon and Rectal Surgery! Ulcerative Colitis v. Crohn s! 30% of

More information

September 12, 2015 Millie D. Long MD, MPH, FACG

September 12, 2015 Millie D. Long MD, MPH, FACG Update on Biologic Therapy in 2015 September 12, 2015 Millie D. Long MD, MPH, FACG Assistant Professor of Medicine Inflammatory Bowel Disease Center University of North Carolina-Chapel Hill Outline Crohn

More information

Inflammatory Bowel Disease When is diarrhea not just diarrhea?

Inflammatory Bowel Disease When is diarrhea not just diarrhea? Inflammatory Bowel Disease When is diarrhea not just diarrhea? Jackie Kazik, MA, PA C CME Resources CAPA Annual Conference, 2011 Inflammatory Bowel Disease Objectives Discuss what is known about the pathophysiology

More information

Understanding Inflammatory Bowel Diseases: What Every Patient Needs to Know

Understanding Inflammatory Bowel Diseases: What Every Patient Needs to Know Understanding Inflammatory Bowel Diseases: What Every Patient Needs to Know An educational program for patients, families and caregivers living with Crohn s disease and ulcerative colitis. Dr. William

More information

INFLIXIMAB Remicade (infliximab), Inflectra (infliximab-dyyb), Ixifi* (infliximabqbtx), Renflexis (infliximab-abda)

INFLIXIMAB Remicade (infliximab), Inflectra (infliximab-dyyb), Ixifi* (infliximabqbtx), Renflexis (infliximab-abda) Pre - PA Allowance None Prior-Approval Requirements Diagnoses Patient must have ONE of the following: 6 years of age or older 1. Moderate to severe Crohn s disease (CD) a. Patient has fistulizing disease

More information

Index. Surg Clin N Am 87 (2007) Note: Page numbers of article titles are in boldface type.

Index. Surg Clin N Am 87 (2007) Note: Page numbers of article titles are in boldface type. Surg Clin N Am 87 (2007) 787 796 Index Note: Page numbers of article titles are in boldface type. A Abscesses in anorectal Crohn s disease, 622 intra-abdominal, in Crohn s disease, 590 591 perirectal,

More information

Hot Topics In Nutrition & IBD January 6, Kate Vance, RD Wael N. Sayej, MD

Hot Topics In Nutrition & IBD January 6, Kate Vance, RD Wael N. Sayej, MD Hot Topics In Nutrition & IBD January 6, 2018 Kate Vance, RD Wael N. Sayej, MD Nutrients of Focus Calories Calcium Vitamin D Iron Nutritional Treatment in IBD Improve nutritional status As primary therapy

More information

We will discuss: Inflammatory Bowel Diseases. Life With IBD. What Are the Potential Causes of IBD?

We will discuss: Inflammatory Bowel Diseases. Life With IBD. What Are the Potential Causes of IBD? We will discuss: Similarities and differences between Crohn s disease (CD) and ulcerative colitis (UC) Risks and benefits of medication, surgery, and integrative treatments in inflammatory bowel diseases

More information

Which is the Safest Strategy to Treat Moderate to Severe IBD?

Which is the Safest Strategy to Treat Moderate to Severe IBD? Which is the Safest Strategy to Treat Moderate to Severe IBD? David G. Binion, M.D. Co-Director, Inflammatory Bowel Disease Center Director, Translational Inflammatory Bowel Disease Research Visiting Professor

More information